Electrophysiologic Abnormalities in AL (Primary) Amyloidosis With Cardiac Involvement
نویسندگان
چکیده
منابع مشابه
Acase report of primary amyloidosis with prominent hepatic involvement
primary amyloidosis is a rare disrder wihich is diagnosed by extracellular deposition of proteinaceous material in different organs.in this report,a case of this disease with prominent hepatic involvement is presented.the case is a 63 years old male refered with abdominal enlargement,weight loss,generalized pruritus,anorexia and vague abdominal pain started from six months ago.on physical exami...
متن کاملAL amyloidosis with renal involvement.
Primary (AL amyloidosis) is a systemic disease characterized by an amyloid deposition process in many organs, with unsatisfactory survival of patients. The monoclonal light chains form the fibrils that deposit and accumulate in tissues. Renal involvement is very frequent in AL amyloidosis and could lead to development of nephrotic syndrome followed by the renal failure in many cases. Classic th...
متن کاملPeritoneal amyloidosis with myopathy in primary systemic (AL) amyloidosis.
To cite: Al-Adhami A, Steiner K, Ellis S. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2016216548 DESCRIPTION We present an unusual case of primary systemic amyloidosis presenting with myopathy and peritoneal amyloid deposition. Peritoneal amyloid is a rare disease with few published cases. An 85-year-old man was referred to rheumatology with walking difficulti...
متن کاملCardiac involvement in familial amyloidosis with polyneuropathy.
Cardiac involvement in familial amyloidosis with polyneuropathy. Peter Eriksson, Department of Internal Medicine, University of Umeå, S-901 85 Umeå, Sweden Familial amyloidosis with polyneuropathy (FAP) is a neuropathic form of heredofamilial systemic amyloidosis. Clusters of patients have been re ported predominantly from Portugal, Japan and Sweden. The present study examines the involvement ...
متن کاملCardiac involvement in cardiac AL amyloidosis as measured by equilibrium contrast cardiovascular magnetic resonance
Background Involvement of the heart drives prognosis in Systemic AL Amyloidosis, predicting outcome and influencing therapeutic options. Current methods of cardiac assessment do not allow formal quantification of the amyloid load. We used Equilibrium Contrast Cardiovascular Magnetic Resonance (EQ-CMR) to measure the interstitial compartment of the heart by measuring the myocardial contrast volu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 1997
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(97)00267-2